XML 31 R10.htm IDEA: XBRL DOCUMENT v3.25.1
RESTRUCTURING CHARGES AND SEPARATION COSTS
 3 Months Ended
Mar. 31, 2025
Restructuring and Related Activities [Abstract]  
RESTRUCTURING CHARGES AND SEPARATION COSTS RESTRUCTURING CHARGES AND SEPARATION COSTS
In September 2024, the Company recorded an expense of $32.9 million related primarily to severance expenses associated with a global workforce realignment impacting approximately 2% of the Company's employees. The following table presents details of the restructuring liability, which is included in Accrued and Other Liabilities:

 Restructuring Liability
 (in millions)
Balance at December 31, 2024
$20.1 
Payments(6.1)
Balance at March 31, 2025
$14.0 

The Company's remaining severance obligations are expected to be substantially paid within the next 12 months.
In the three months ended March 31, 2025, the Company recorded expenses of $4.2 million, primarily related to costs incurred for professional advisory services associated with the sale of Critical Care. For further information, see Note 4.